Genus Plc Stock Today
| GENSF Stock | USD 20.90 0.00 0.00% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Genus Plc is trading at 20.90 as of the 2nd of December 2024. This is a No Change since the beginning of the trading day. The stock's lowest day price was 20.9. Genus Plc has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Genus plc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 5th of June 2024 and ending today, the 2nd of December 2024. Click here to learn more.
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom. Genus Plc operates under Biotechnology classification in the United States and is traded on OTC Exchange. The company has 65.77 M outstanding shares. More on Genus plc
Moving against Genus Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Genus Pink Sheet Highlights
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Genus plc [GENSF] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC). The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.27 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Genus Plc's market, we take the total number of its shares issued and multiply it by Genus Plc's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Genus plc classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 65.77 M outstanding shares.
Genus plc has accumulated about 38.8 M in cash with 34.3 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.59.
Check Genus Plc Probability Of Bankruptcy
Ownership AllocationGenus plc has a total of 65.77 Million outstanding shares. The majority of Genus plc outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Genus Plc to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Genus plc. Please pay attention to any change in the institutional holdings of Genus plc as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Genus Ownership Details
Genus plc Risk Profiles
| Mean Deviation | 0.4635 | |||
| Standard Deviation | 1.75 | |||
| Variance | 3.05 | |||
| Risk Adjusted Performance | (0.01) |
Genus Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Genus Plc without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Instant Ratings Now
Instant RatingsDetermine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Genus Plc Corporate Executives
Elected by the shareholders, the Genus Plc's board of directors comprises two types of representatives: Genus Plc inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Genus. The board's role is to monitor Genus Plc's management team and ensure that shareholders' interests are well served. Genus Plc's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Genus Plc's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Nate Zwald | COO, Genus ABS Dairy | Profile | |
| Jerry Thompson | COO, Genus Asia | Profile |
Other Information on Investing in Genus Pink Sheet
Genus Plc financial ratios help investors to determine whether Genus Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Genus with respect to the benefits of owning Genus Plc security.